Public Employees Retirement Association of Colorado Trims Stock Holdings in Masimo Co. (NASDAQ:MASI)

Public Employees Retirement Association of Colorado lessened its stake in shares of Masimo Co. (NASDAQ:MASI) by 4.6% in the second quarter, HoldingsChannel reports. The firm owned 4,841 shares of the medical equipment provider’s stock after selling 234 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Masimo were worth $610,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in shares of Masimo by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 4,781,343 shares of the medical equipment provider’s stock worth $560,421,000 after purchasing an additional 26,473 shares during the period. Capital Research Global Investors lifted its position in Masimo by 6.4% during the fourth quarter. Capital Research Global Investors now owns 2,269,189 shares of the medical equipment provider’s stock worth $265,972,000 after buying an additional 136,617 shares during the period. Farallon Capital Management LLC lifted its position in Masimo by 13.6% during the first quarter. Farallon Capital Management LLC now owns 1,489,563 shares of the medical equipment provider’s stock worth $218,742,000 after buying an additional 177,914 shares during the period. Schroder Investment Management Group boosted its stake in Masimo by 59.6% in the 4th quarter. Schroder Investment Management Group now owns 877,539 shares of the medical equipment provider’s stock worth $102,856,000 after buying an additional 327,863 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Masimo by 45.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider’s stock valued at $66,201,000 after buying an additional 165,257 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Trading Down 0.5 %

NASDAQ MASI opened at $133.10 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.15 and a current ratio of 2.09. Masimo Co. has a one year low of $75.22 and a one year high of $153.93. The company’s 50 day moving average price is $116.67 and its 200 day moving average price is $124.97. The firm has a market capitalization of $7.08 billion, a price-to-earnings ratio of 90.54 and a beta of 0.98.

Masimo (NASDAQ:MASI) last posted its earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.09. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The business had revenue of $496.30 million for the quarter, compared to analyst estimates of $493.92 million. During the same quarter in the previous year, the business posted $0.62 EPS. The business’s quarterly revenue was up 9.0% on a year-over-year basis. On average, sell-side analysts predict that Masimo Co. will post 3.87 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on MASI shares. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a report on Friday, September 20th. Piper Sandler increased their price target on shares of Masimo from $160.00 to $165.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $144.67.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.